Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort

This diagnostic study evaluates the performance of 3 ultrasonography-based risk models for differentiating between benign and malignant adnexal lesions in a US cohort.

[1]  A. Shinagare,et al.  Adnexal Lesion Imaging: Past, Present, and Future. , 2023, Radiology.

[2]  D. Jurković.  Conservative management of adnexal tumors: how to tell good from bad , 2023, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[3]  A. Jemal,et al.  Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[4]  B. van Calster,et al.  External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups , 2022, JAMA oncology.

[5]  D. Levine,et al.  Ovarian-Adnexal Reporting and Data System for Ultrasound: A Framework for Improvement , 2022, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[6]  Deborah A Baumgarten.  O-RADS: Good Enough for Everyday Practice or a Work in Progress? , 2022, Radiology. Imaging cancer.

[7]  M. D. del Carmen,et al.  Lesions of the Ovary and Fallopian Tube. , 2022, The New England journal of medicine.

[8]  E. Lengyel,et al.  A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing , 2022, bioRxiv.

[9]  L. Larkin,et al.  Management of the Adnexal Mass: Considerations for the Family Medicine Physician , 2022, Frontiers in Medicine.

[10]  K. Maturen,et al.  Diagnostic Performance of the Ovarian-Adnexal Reporting and Data System (O-RADS) Ultrasound Risk Score in Women in the United States , 2022, JAMA network open.

[11]  Yen-Hou Chang,et al.  Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions , 2022, European Radiology.

[12]  Niket Gandhi,et al.  External Validation of O-RADS US Risk Stratification and Management System. , 2022, Radiology.

[13]  Hui-Ni Chen,et al.  Deep Learning Prediction of Ovarian Malignancy at US Compared with O-RADS and Expert Assessment. , 2022, Radiology.

[14]  Deborah A Baumgarten.  A Simplified Approach to Adnexal Lesions May Be Enough. , 2022, Radiology.

[15]  Jieyu Liu,et al.  A comparison of the diagnostic performance of the O-RADS, RMI4, IOTA LR2, and IOTA SR systems by senior and junior doctors , 2022, Ultrasonography.

[16]  A. Hiett,et al.  Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O‐RADS in differentiating between benign and malignant adnexal lesions in North American women , 2021, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[17]  T. Bourne,et al.  ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours , 2021, Facts, views & vision in ObGyn.

[18]  Jianhua Zhou,et al.  Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses. , 2021, Gynecologic oncology.

[19]  K. Maturen,et al.  Contemporary Guidelines for Adnexal Mass Imaging: A 2020 Update , 2020, Abdominal Radiology.

[20]  O. Harb,et al.  Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses , 2020, European Radiology.

[21]  P. Glanc,et al.  Guideline No. 404: Initial Investigation and Management of Benign Ovarian Masses. , 2020, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[22]  T. Bourne,et al.  Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study , 2020, BMJ.

[23]  P. Zola,et al.  The ADNEX model to triage adnexal masses: An external validation study and comparison with the IOTA two-step strategy and subjective assessment by an experienced ultrasound operator. , 2020, European journal of obstetrics, gynecology, and reproductive biology.

[24]  R. Porcher,et al.  Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses , 2020, JAMA network open.

[25]  M. Jiang,et al.  Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China , 2019, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[26]  D. Timmerman,et al.  Methods of Assessing Ovarian Masses: International Ovarian Tumor Analysis Approach. , 2019, Obstetrics and gynecology clinics of North America.

[27]  E. Puscheck,et al.  Simple Adnexal Cysts: SRU Consensus Conference Update on Follow-up and Reporting. , 2019, Radiology.

[28]  Paul A. Harris,et al.  The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.

[29]  M. Stukan,et al.  Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: an observational study , 2019, BMC Cancer.

[30]  T. Bourne,et al.  Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study. , 2019, The Lancet. Oncology.

[31]  D. Miglioretti,et al.  Risk of Malignant Ovarian Cancer Based on Ultrasonography Findings in a Large Unselected Population , 2019, JAMA internal medicine.

[32]  T. Bourne,et al.  Ovarian-Adnexal Reporting Lexicon for Ultrasound: A White Paper of the ACR Ovarian-Adnexal Reporting and Data System Committee. , 2018, Journal of the American College of Radiology : JACR.

[33]  J. Kleijnen,et al.  Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis. , 2018, Health technology assessment.

[34]  B. van Calster,et al.  External validation of ADNEX model for diagnosing ovarian cancer: evaluating performance of differentiation between tumor subgroups , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[35]  D. Timmerman,et al.  Ovarian mass-differentiating benign from malignant: the value of the International Ovarian Tumor Analysis ultrasound rules. , 2017, American journal of obstetrics and gynecology.

[36]  T. Van Gorp,et al.  Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[37]  T. Bourne,et al.  First International Consensus Report on Adnexal Masses: Management Recommendations , 2017, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[38]  T. Bourne,et al.  Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study , 2016, British Journal of Cancer.

[39]  D Timmerman,et al.  Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis. , 2016, European journal of cancer.

[40]  T. Bourne,et al.  Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group. , 2016, American Journal of Obstetrics and Gynecology.

[41]  D. Oram,et al.  Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial , 2016, The Lancet.

[42]  David Moher,et al.  STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies , 2015, BMJ : British Medical Journal.

[43]  Dirk Timmerman,et al.  Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study , 2014, BMJ : British Medical Journal.

[44]  S. Huffel,et al.  Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature , 2013, Ultrasound in Obstetrics and Gynecology.

[45]  Sabine Van Huffel,et al.  Extending the c‐statistic to nominal polytomous outcomes: the Polytomous Discrimination Index , 2012, Statistics in medicine.

[46]  H. Dickinson,et al.  Centralisation of services for gynaecological cancers - a Cochrane systematic review. , 2012, Gynecologic oncology.

[47]  J. Gohagan,et al.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. , 2011, JAMA.

[48]  Sabine Van Huffel,et al.  Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group , 2010, BMJ : British Medical Journal.

[49]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[50]  D. Jurkovic,et al.  Simple ultrasound‐based rules for the diagnosis of ovarian cancer , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[51]  Y. van der Graaf,et al.  The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. , 2007, Gynecologic oncology.

[52]  B. Rosen,et al.  Who should operate on patients with ovarian cancer? An evidence-based review. , 2005, Gynecologic oncology.

[53]  D. Altman,et al.  Diagnostic tests 4: likelihood ratios , 2004, BMJ : British Medical Journal.

[54]  T. Bourne,et al.  Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[55]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[56]  T. Bourne,et al.  O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. , 2019, Radiology.